Literature DB >> 20026021

Screening for inborn errors of metabolism using automated electrospray tandem mass spectrometry: study in high-risk Indian population.

Dindagur Nagaraja1, Sopanahalli Narasimhamurthy Mamatha, Tanima De, Rita Christopher.   

Abstract

OBJECTIVES: Tandem mass spectrometry is a major technological advance in the screening for inborn errors of metabolism. It has the advantage of sensitive and simultaneous multiple disease screening with minimal sample requirement. The diseases detected include aminoacidemias, fatty acid oxidation disorders, and organic acidemias. DESIGN AND METHODS: Using automated electrospray tandem mass spectrometry we screened 3550, clinically selected, symptomatic children for inborn errors of metabolism by analyzing amino acids and acylcarnitines in dried blood filter-paper samples.
RESULTS: Among these, 113 (3.2%) children were identified with a metabolic disorder: 61 (54%) patients had amino acid disorders, 47 (41.6%) had organic acidemias, and 5 (4.4%) children had disorders of fatty acid oxidation. The diagnoses were further confirmed through clinical symptoms, and other biochemical studies.
CONCLUSIONS: These results show that inherited metabolic disorders are not rare in India, a rapidly developing country with a high birth rate and relatively frequent occurrence of consanguineous marriages. Copyright 2009 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 20026021     DOI: 10.1016/j.clinbiochem.2009.12.009

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  16 in total

1.  Status of Newborn Screening and Inborn Errors of Metabolism in India.

Authors:  Seema Kapoor; B K Thelma
Journal:  Indian J Pediatr       Date:  2018-05-07       Impact factor: 1.967

2.  Organic acidurias: an updated review.

Authors:  Kannan Vaidyanathan; M P Narayanan; D M Vasudevan
Journal:  Indian J Clin Biochem       Date:  2011-04-29

3.  Diagnosis of major organic acidurias in children: two years experience at a tertiary care centre.

Authors:  M P Narayanan; Vaidyanathan Kannan; K P Vinayan; D M Vasudevan
Journal:  Indian J Clin Biochem       Date:  2011-02-01

4.  Impact of inborn errors of metabolism on admission in a neonatal intensive care unit--a prospective cohort study.

Authors:  Wenjun Tu; Jian He; Fang Dai; Xinyu Wang; Ying Li
Journal:  Indian J Pediatr       Date:  2011-06-10       Impact factor: 1.967

5.  Screening and follow-up results of fatty acid oxidative metabolism disorders in 608 818 newborns in Jining, Shandong province.

Authors:  Chiju Yang; Caihong Shi; Cheng Zhou; Qiuhua Wan; Yanbin Zhou; Xigui Chen; Xianlian Jin; Chenggang Huang; Peng Xu
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-08-25

6.  High Risk Stratified Neonatal Screening.

Authors: 
Journal:  Indian J Pediatr       Date:  2018-03-15       Impact factor: 1.967

7.  Screening for inborn errors of metabolism in high-risk children: a 3-year pilot study in Zhejiang Province, China.

Authors:  Xinwen Huang; Lili Yang; Fan Tong; Rulai Yang; Zhengyan Zhao
Journal:  BMC Pediatr       Date:  2012-02-24       Impact factor: 2.125

8.  Efficacy of fermentation parameters on protein quality and microstructural properties of processed finger millet flour.

Authors:  Gowthamraj G; Raasmika M; Sangeetha Narayanasamy
Journal:  J Food Sci Technol       Date:  2020-10-06       Impact factor: 3.117

9.  Demographic and Clinical Findings in Pediatric Patients Affected by Organic Acidemia.

Authors:  Reza Najafi; Mahin Hashemipour; Neda Mostofizadeh; Mohammadreza Ghazavi; Jafar Nasiri; Armindokht Shahsanai; Fatemeh Famori; Fatemeh Najafi; Mohammad Moafi
Journal:  Iran J Child Neurol       Date:  2016

10.  Audit of Organic Acidurias from a Single Centre: Clinical and Metabolic Profile at Presentation with Long Term Outcome.

Authors:  Seema Pavaman Sindgikar; Krithika Damodar Shenoy; Nutan Kamath; Rathika Shenoy
Journal:  J Clin Diagn Res       Date:  2017-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.